ARCHIVES

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

This article is from The Cancer Letter archive.

Vol. 31 No. 01 | January 7, 2005

Download PDF Visit The Full Archive

Related Articles

ACS to Purchase $1.5 Million In animal Interferon, Offer it for Laboratory Studies

July 13, 1984

Van Potter Wins Bristol-Myers Award

April 24, 1981

Surgical Oncology Planners Develop NCPP research Approaches, Projects

May 24, 1974

Progress Requires More Etiologists, D’Angio Says

September 15, 1978

White House Backs Down FY 86 Cuts, Says Now They Will Be Limited To Trimming Indirect Costs

January 10, 1986

Public Health Service: Blumenthal Declines White House Job

November 14, 1997